Literature DB >> 21172203

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study.

Pascal Juillerat1, Valérie Pittet, Jean-Luc Bulliard, Idris Guessous, Anca Teodora Antonino, Christian Mottet, Christian Felley, John-Paul Vader, Pierre Michetti.   

Abstract

BACKGROUND AND AIMS: Because of the changing epidemiology of Inflammatory Bowel Diseases (IBD), we set out to characterize the population-based prevalence of Crohn's Disease (CD) and Ulcerative Colitis (UC) in a defined population of Switzerland.
METHODS: Adult IBD patients were identified by a cross-matched review of histological, hospital and gastroenterologist files throughout a geographical defined population (Canton of Vaud). Demographic factors statistically significantly associated with prevalence were evaluated using a stepwise Poisson regression analysis. Results were compared to IBD prevalence rates in other population-based studies and time trends were performed, based on a systematic literature review.
RESULTS: Age and sex-adjusted prevalence rates were 205.7 IBD (100.7 CD and 105.0 UC) cases per 10(5) inhabitants. Among 1016 IBD patients (519 CD and 497 UC), females outnumbered males in CD (p<0.001), but males were more represented in elderly UC patients (p=0.008). Thus, being a male was statistically associated with UC (Relative Risk (RR) 1.25; p=0.013), whereas being a female was associated with CD (RR 1.27; p=0.007). Living in an urban zone was associated with both CD and UC (RR 1.49; p<0.001, 1.63; p<0.001, respectively). From 1960 to 2005, increases in UC and CD prevalences of 2.4% (95%CI, 2.1%-2.8%; p<0.001) and 3.6% (95%CI, 3.1%-4.1%; p<0.001) per annum were found in industrialised countries.
CONCLUSIONS: Extrapolating our data to all of Switzerland yields an estimate of 12,000 IBD cases for the country, or 1 in 500 inhabitants. Our study gives support to an increase in IBD prevalence in Europe.

Entities:  

Year:  2007        PMID: 21172203     DOI: 10.1016/j.crohns.2007.10.006

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  11 in total

1.  Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition"?

Authors:  Saurabh Kedia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2018-06-12

Review 2.  Environmental triggers in IBD: a review of progress and evidence.

Authors:  Ashwin N Ananthakrishnan; Charles N Bernstein; Dimitrios Iliopoulos; Andrew Macpherson; Markus F Neurath; Raja A Raja Ali; Stephan R Vavricka; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

Review 3.  Eosinophilic esophagitis: What can we learn from Crohn's disease?

Authors:  Javier Molina-Infante; Alain M Schoepfer; Alfredo J Lucendo; Evan S Dellon
Journal:  United European Gastroenterol J       Date:  2016-09-29       Impact factor: 4.623

4.  Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparison.

Authors:  Patricia Halfon; Yves Eggli; Anne Decollogny; Erol Seker
Journal:  BMC Health Serv Res       Date:  2013-10-31       Impact factor: 2.655

5.  VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study.

Authors:  Susann Hasler; Nadine Zahnd; Salomé Müller; Stephan Vavricka; Gerhard Rogler; Ryan Tandjung; Thomas Rosemann
Journal:  BMJ Open       Date:  2015-03-10       Impact factor: 2.692

6.  The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.

Authors:  Keeley L Rose; Philip M Sherman; Jane Cooke-Lauder; Mina Mawani; Eric I Benchimol; Gilaad G Kaplan; Charles N Bernstein; Alain Bitton; Sanjay K Murthy; Geoffrey C Nguyen; Kate Lee
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

7.  Development of a Global Rating Scale for Inflammatory Bowel Disease.

Authors:  Alain Bitton; Katharine S Devitt; Brian Bressler; Joan Heatherington; Vipul Jairath; Jennifer Jones; Paul Moayyedi; Adam V Weizman; Catherine Dubé; Donald MacIntosh; Geoffrey C Nguyen
Journal:  J Can Assoc Gastroenterol       Date:  2019-06-11

8.  Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.

Authors:  Caroline Bähler; Stephan R Vavricka; Alain M Schoepfer; Beat Brüngger; Oliver Reich
Journal:  BMC Gastroenterol       Date:  2017-12-02       Impact factor: 3.067

9.  Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis.

Authors:  Damián García-Olmo; Gert Van Assche; Ignacio Tagarro; Mary Carmen Diez; Marie Paule Richard; Javaria Mona Khalid; Marc van Dijk; Dimitri Bennett; Suvi R K Hokkanen; Julián Panés
Journal:  Adv Ther       Date:  2019-10-26       Impact factor: 3.845

10.  Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study.

Authors:  Corinne Chmiel; Oliver Senn; Susann Hasler; Thomas Rosemann; Gerhard Rogler; Nadine Zahnd; Ryan Tandjung; Nathalie Scherz; Michael Christian Sulz; Stephan Vavricka
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.